Lab follow-ups are typically scheduled at 3 months, 6 months, and then every 6 months thereafter
It is not a medicine, food, supplement, cosmetic, or medical device, and is not for human or veterinary use, administration, or consumption
Surgery success rates are generally good for pain relief (70 to 90% improvement in leg pain symptoms), but come with risks: infection, nerve damage, disc reherniation (5 to 15% recurrence rate after microdiscectomy), and adjacent segment disease with fusion (20 to 30% develop problems within 10 years)
This guide breaks down exactly how it works, who its for, and what realistic results look like
The ACVIM pretty much has soiled itself by knowingly choosing a consensus panel consisting totally of authors who have been paid consultants to the sole manufacturer of the drug which they unanimously advocate for treating pre-CHF MVD-affected dogs